German Congress for Orthopaedics and Accident Surgery (DKOU): positive results for co.don AG
(Thomson Reuters ONE) -
co.don AG /
German Congress for Orthopaedics and Accident Surgery (DKOU): positive results
for co.don AG
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
+ Interest in regenerative therapies for the treatment of articular cartilage
defects continues to grow
+ Successful workshop as part of the DKOU
Berlin / Teltow - Interest in regenerative medicine continues to grow,
especially in the field of orthopaedics and above all for joints. This is how
Teltow-based biopharma company co.con summed up the results of the German
Congress for Orthopaedics and Accident Surgery in Berlin, which set a new record
for visitor numbers with some 11,600 participants. Dr. Andreas Baltrusch, CEO of
the company: "You have to remember that according to experts around 20 per cent
of all the knee and hip operations involving partial or full prostheses can be
avoided if treatment is carried out at an early stage using minimally invasive
regenerative methods. This explains the growing interest on the part of
specialist surgeons in methods that preserve the joint, such as those offered by
co.don."
The procedure developed by co.don of removing, cultivating and re-implanting
autologous cartilage cells means that a lasting treatment is often possible for
cartilage defects, and that the need for an artificial knee or hip joint can
often be averted. The co.don Hands-On Workshop during the Congress met with keen
interest as a result. During the workshop surgeons had the opportunity of
testing the matrix-associated chondrocyte transplants with spheroids in a
product. They were assisted by the experienced surgeons Dr. med. Volker Laute,
Head of the Knee Surgery Section and Medical Director of the Articular and
Spinal Centre Berlin, and Dr. med. Tobias Jung, Head of Section and senior
consultant for Accident and Repair Surgery at the Charité University Hospital in
Berlin.
co.don AG has specialised in cultivating cartilage tissue for twenty years. The
company is based in Teltow, Brandenburg, and has developed a patented and tested
method of cultivating and re-implanting autologous chondrocytes. This enables
cartilage defects to be treated by minimally invasive transplantation, using
nothing but the patient's own cells. There is no need to stick, suture or cover
the spheroids. To date the treatment has been applied successfully to articular
defects in around 5,500 patients in Germany. The company is currently in the
process of obtaining European marketing authorisation for the co.don therapy.
About co.don(®) AG:
The company is based in Teltow, Brandenburg, and was founded in 1993. Since
2001 the biopharmaceutical specialist has been listed on the Frankfurt Stock
Exchange (ISIN: DE000A1K0227). co.don AG(®) uses tissue engineering - the
cultivation and growth of autologous tissue cells - to develop innovative
products and therapeutic concepts for the orthopaedic and neurosurgical markets.
The cell-based biological drugs (autologous cell transplants for articular
cartilage and intervertebral disks) are produced without the use of antibiotics,
growth factors and genetic engineering. The Executive Board of co.don(®) AG is
made up of Dr Andreas Baltrusch (CEO) and Ms Vilma Methner (COO, CSO).
Further information is available from: www.codon.de
Press contact
Jens Secker
BrunoMedia GmbH | Dreikönigshof | Martinsstraße 17 | D-55116 Mainz
Tel +49 6131 930 28 33
Fax +49 6131 930 28 34
E-Mail secker(at)brunomedia.de
Internet www.brunomedia.de
Press release (PDF):
http://hugin.info/132731/R/1739153/583625.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: co.don AG via Thomson Reuters ONE
[HUG#1739153]
Unternehmensinformation / Kurzprofil:
Datum: 30.10.2013 - 10:04 Uhr
Sprache: Deutsch
News-ID 310707
Anzahl Zeichen: 4625
contact information:
Town:
Teltow
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 201 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"German Congress for Orthopaedics and Accident Surgery (DKOU): positive results for co.don AG"
steht unter der journalistisch-redaktionellen Verantwortung von
co.don AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
